Denmarks Novo set down a marker last month, with the US launch of its daily pill the first oral GLP-1 drug for weight loss
Possible Side Effects Like other incretin-based therapies, Retatrutide may cause some side effects
Choosing Between Ipamorelin and Sermorelin While ipamorelin is often discussed in general peptide therapy comparisons, our clinical protocols focus exclusively on sermorelin due to its ability to support long-term hormone rhythm
The guidance suggests that medication holds or procedure delays should be considered primarily for patients with significant risk factors or symptoms suggesting delayed gastric emptying
The primary analysis included nearly 95,000 women between the ages of 45 and 80 who had a body mass index above 25, placing them in the overweight or obesity categories
For people with type 2 diabetes or clinical obesity, replacing evidence-based pharmaceutical treatment with an unproven supplement carries health risks that extend beyond simply not losing weight